Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Implementation of a Novel Curriculum and Fostering Professional Identity Formation of Pediatrician-Scientists.

Burns AM, Thammasitboon S, Ward MA, Kline MW, Raphael JL, Turner TL, Orange JS.

J Pediatr. 2019 Feb;205:5-7.e1. doi: 10.1016/j.jpeds.2018.11.031. No abstract available.

PMID:
30684987
2.

Lost to follow-up: failure to engage children in care in the first three months of diagnosis.

Machine EM, Gillespie SL, Homedes N, Selwyn BJ, Ross MW, Anabwani G, Schutze G, Kline MW.

AIDS Care. 2016 Nov;28(11):1402-10. doi: 10.1080/09540121.2016.1179714. Epub 2016 May 10.

3.

Strengthening the Pipeline for Clinician-Scientists: The Pediatrician-Scientist Training and Development Program at Texas Children's Hospital.

Burns AM, Kushner JA, Ward MA, Turner TL, Kline MW, Orange JS.

J Pediatr. 2016 May;172:5-6.e5. doi: 10.1016/j.jpeds.2016.02.002. No abstract available.

PMID:
27112081
4.

What Pediatricians and Other Clinicians Should Know About Zika Virus.

Kline MW, Schutze GE.

JAMA Pediatr. 2016 Apr;170(4):309-10. doi: 10.1001/jamapediatrics.2016.0429. No abstract available.

PMID:
26893150
5.

The Pediatric AIDS Corps: a 5-year evaluation.

Schutze GE, Ferris MG, Jones DC, Wanless RS, Calles NR, Mizwa MB, Schwarzwald H, Kline MW.

Pediatrics. 2014 Jun;133(6):e1548-54. doi: 10.1542/peds.2013-2938.

PMID:
24864179
6.

Nine-year follow-up of HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy.

Wanless RS, Rugină S, Ruţă SM, Dumitru IM, Cernat RC, Schwarzwald HL, Calles NR, Schutze GE, Schweitzer AM, Draper HR, Kline MW.

Germs. 2013 Sep 1;3(3):90-5. doi: 10.11599/germs.2013.1042. eCollection 2013 Sep 1.

7.

A conversation with Mark W. Kline, MD. Interview by Stanford T Shulman.

Kline MW.

Pediatr Ann. 2013 Sep;42(9):384. doi: 10.3928/00904481-20130823-14. No abstract available.

PMID:
23992221
8.

Routine inpatient provider-initiated HIV testing in Malawi, compared with client-initiated community-based testing, identifies younger children at higher risk of early mortality.

Preidis GA, McCollum ED, Kamiyango W, Garbino A, Hosseinipour MC, Kazembe PN, Schutze GE, Kline MW.

J Acquir Immune Defic Syndr. 2013 May 1;63(1):e16-22. doi: 10.1097/QAI.0b013e318288aad6.

9.

Mortality and clinical outcomes in HIV-infected children on antiretroviral therapy in Malawi, Lesotho, and Swaziland.

Kabue MM, Buck WC, Wanless SR, Cox CM, McCollum ED, Caviness AC, Ahmed S, Kim MH, Thahane L, Devlin A, Kochelani D, Kazembe PN, Calles NR, Mizwa MB, Schutze GE, Kline MW.

Pediatrics. 2012 Sep;130(3):e591-9. doi: 10.1542/peds.2011-1187. Epub 2012 Aug 13.

10.

The Tingathe programme: a pilot intervention using community health workers to create a continuum of care in the prevention of mother to child transmission of HIV (PMTCT) cascade of services in Malawi.

Kim MH, Ahmed S, Buck WC, Preidis GA, Hosseinipour MC, Bhalakia A, Nanthuru D, Kazembe PN, Chimbwandira F, Giordano TP, Chiao EY, Schutze GE, Kline MW.

J Int AIDS Soc. 2012 Jul 11;15 Suppl 2:17389. doi: 10.7448/IAS.15.4.17389.

11.

Prompt initiation of ART With therapeutic food is associated with improved outcomes in HIV-infected Malawian children with malnutrition.

Kim MH, Cox C, Dave A, Draper HR, Kabue M, Schutze GE, Ahmed S, Kazembe PN, Kline MW, Manary M.

J Acquir Immune Defic Syndr. 2012 Feb 1;59(2):173-6. doi: 10.1097/QAI.0b013e3182405f8f.

PMID:
22107819
12.

Pneumonia and malnutrition are highly predictive of mortality among African children hospitalized with human immunodeficiency virus infection or exposure in the era of antiretroviral therapy.

Preidis GA, McCollum ED, Mwansambo C, Kazembe PN, Schutze GE, Kline MW.

J Pediatr. 2011 Sep;159(3):484-9. doi: 10.1016/j.jpeds.2011.02.033. Epub 2011 Apr 13.

13.

Routine inpatient human immunodeficiency virus testing system increases access to pediatric human immunodeficiency virus care in sub-Saharan Africa.

McCollum ED, Preidis GA, Golitko CL, Siwande LD, Mwansambo C, Kazembe PN, Hoffman I, Hosseinipour MC, Schutze GE, Kline MW.

Pediatr Infect Dis J. 2011 May;30(5):e75-81. doi: 10.1097/INF.0b013e3182103f8a.

14.

Inadequate coordination of maternal and infant HIV services detrimentally affects early infant diagnosis outcomes in Lilongwe, Malawi.

Braun M, Kabue MM, McCollum ED, Ahmed S, Kim M, Aertker L, Chirwa M, Eliya M, Mofolo I, Hoffman I, Kazembe PN, van der Horst C, Kline MW, Hosseinipour MC.

J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):e122-8. doi: 10.1097/QAI.0b013e31820a7f2f.

15.

Discontinuation of standard first-line antiretroviral therapy in a cohort of 1434 Malawian children.

Buck WC, Kabue MM, Kazembe PN, Kline MW.

J Int AIDS Soc. 2010 Aug 6;13:31. doi: 10.1186/1758-2652-13-31.

16.

Task shifting routine inpatient pediatric HIV testing improves program outcomes in urban Malawi: a retrospective observational study.

McCollum ED, Preidis GA, Kabue MM, Singogo EB, Mwansambo C, Kazembe PN, Kline MW.

PLoS One. 2010 Mar 10;5(3):e9626. doi: 10.1371/journal.pone.0009626.

17.

Effectiveness of a training program to increase the capacity of health care providers to provide HIV/AIDS care and treatment in Swaziland.

Kamiru HN, Ross MW, Bartholomew LK, McCurdy SA, Kline MW.

AIDS Care. 2009 Nov;21(11):1463-70. doi: 10.1080/09540120902883093.

18.

Early clinical outcomes in children enrolled in human immunodeficiency virus infection care and treatment in lesotho.

Leyenaar JK, Novosad PM, Ferrer KT, Thahane LK, Mohapi EQ, Schutze GE, Kline MW.

Pediatr Infect Dis J. 2010 Apr;29(4):340-5. doi: 10.1097/INF.0b013e3181bf8ecb.

PMID:
20019645
19.

Early exclusive breastfeeding: still the cornerstone of child survival.

Kline MW.

Am J Clin Nutr. 2009 May;89(5):1281-2. doi: 10.3945/ajcn.2009.27743. Epub 2009 Apr 1. No abstract available.

PMID:
19339392
20.

The Pediatric AIDS Corps: responding to the African HIV/AIDS health professional resource crisis.

Kline MW, Ferris MG, Jones DC, Calles NR, Mizwa MB, Schwarzwald HL, Wanless RS, Schutze GE.

Pediatrics. 2009 Jan;123(1):134-6. doi: 10.1542/peds.2008-0402.

PMID:
19117871
21.

Education and preparation of physicians entering an international pediatric AIDS program: the Pediatric AIDS Corps.

Schutze GE, Ferris MG, Jones DC, Calles NR, Mizwa MB, Schwarzwald HL, Wanless RS, Kline MW.

AIDS Patient Care STDS. 2008 Sep;22(9):709-14. doi: 10.1089/apc.2007.0230.

PMID:
18754707
22.

Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda.

Kabue MM, Kekitiinwa A, Maganda A, Risser JM, Chan W, Kline MW.

AIDS Patient Care STDS. 2008 Mar;22(3):245-51. doi: 10.1089/apc.2007.0049.

PMID:
18298315
23.

Influence of institutionalization on time to HIV disease progression in a cohort of Romanian children and teens.

Ferris M, Burau K, Constantin AM, Mihale S, Murray N, Preda A, Ross M, Kline MW.

Pediatrics. 2007 Dec;120(6):e1476-80.

PMID:
18055665
24.

Long-term follow-up of 414 HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy.

Kline MW, Rugina S, Ilie M, Matusa RF, Schweitzer AM, Calles NR, Schwarzwald HL.

Pediatrics. 2007 May;119(5):e1116-20. Epub 2007 Apr 9.

PMID:
17420261
25.
26.

Pediatric and adult HIV/AIDS treatment: still worlds apart.

Kline MW.

Res Initiat Treat Action. 2005 Fall;11(2):22-3. No abstract available.

PMID:
16456981
27.

A simplified weight-based method for pediatric drug dosing for zidovudine and didanosine in resource-limited settings.

Weidle PJ, Abrams EJ, Gvetadze R, Rivadeneira E, Kline MW.

Pediatr Infect Dis J. 2006 Jan;25(1):59-64.

PMID:
16395105
28.

Longitudinal study of the prevalence and prognostic implications of oral manifestations in romanian children infected with human immunodeficiency virus type 1.

Vaseliu N, Carter AB, Kline NE, Kozinetz C, Cron SG, Matusa R, Kline MW.

Pediatr Infect Dis J. 2005 Dec;24(12):1067-71.

PMID:
16371867
29.

High prevalence of hepatitis B virus markers in Romanian adolescents with human immunodeficiency virus infection.

Ruta SM, Matusa RF, Sultana C, Manolescu L, Kozinetz CA, Kline MW, Cernescu C.

MedGenMed. 2005 Mar 28;7(1):68.

30.

Treatment of human immunodeficiency virus (HIV) in children using antiretroviral drugs.

Anabwani GM, Woldetsadik EA, Kline MW.

Semin Pediatr Infect Dis. 2005 Apr;16(2):116-24. Review.

PMID:
15825142
31.

High prevalence of hepatitis B virus markers in romanian adolescents with human immunodeficiency virus infection.

Ruta SM, Matusa RF, Sultana C, Manolescu L, Kozinetz CA, Kline MW, Cernescu C.

J Int AIDS Soc. 2005 Mar 25;7(1):68. doi: 10.1186/1758-2652-7-1-68.

32.

Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.

Hughes WT, Dankner WM, Yogev R, Huang S, Paul ME, Flores MA, Kline MW, Wei LJ; Pediatric AIDS Clinical Trials Group 254 Team.

Clin Infect Dis. 2005 Jan 1;40(1):136-45. Epub 2004 Dec 6.

PMID:
15614703
33.
34.

No greater gift than hope.

Kline MW.

Semin Pediatr Infect Dis. 2003 Oct;14(4):309-13. Review. No abstract available.

PMID:
14724795
35.

Human immunodeficiency virus protease inhibitors.

Kline MW.

Pediatr Infect Dis J. 2003 Dec;22(12):1085-7. Review. No abstract available.

PMID:
14688570
37.

Disseminated Acanthamoeba infection in a human immunodeficiency virus-infected infant.

Schwarzwald H, Shah P, Hicks J, Levy M, Wagner ML, Kline MW.

Pediatr Infect Dis J. 2003 Feb;22(2):197-9.

PMID:
12613458
38.

False negative DNA polymerase chain reaction in an infant with subtype C human immunodeficiency virus 1 infection.

Kline NE, Schwarzwald H, Kline MW.

Pediatr Infect Dis J. 2002 Sep;21(9):885-6.

PMID:
12380591
39.

Pharmacokinetics of saquinavir in children during long term treatment.

Grub S, Schwarzwald HL, Kline MW, Jorga K.

Pediatr Infect Dis J. 2002 Jul;21(7):712-3. No abstract available.

PMID:
12237613
40.

Efavirenz liquid formulation in human immunodeficiency virus-infected children.

Starr SE, Fletcher CV, Spector SA, Brundage RC, Yong FH, Douglas SD, Flynn PM, Kline MW; PACTG 382 Study Team. Pediatric AIDS Clinical Trials Group.

Pediatr Infect Dis J. 2002 Jul;21(7):659-63.

PMID:
12237599
41.

Magnitude of IFN-gamma production in HIV-1-infected children is associated with virus suppression.

Reuben JM, Lee BN, Paul M, Kline MW, Cron SG, Abramson S, Lewis D, Kozinetz CA, Shearer WT.

J Allergy Clin Immunol. 2002 Aug;110(2):255-61.

PMID:
12170266
42.

Lipodystrophy syndrome in human immunodeficiency virus-infected children.

Amaya RA, Kozinetz CA, McMeans A, Schwarzwald H, Kline MW.

Pediatr Infect Dis J. 2002 May;21(5):405-10.

PMID:
12150177
43.

Editorial comment: challenges to pediatric adherence to antiretroviral medications.

Ferris MG, Kline MW.

AIDS Read. 2002 Apr;12(4):162-3. No abstract available.

PMID:
12071186
44.

Selection of zidovudine resistance mutations and escape of human immunodeficiency virus type 1 from antiretroviral pressure in stavudine-treated pediatric patients.

Maxeiner HG, Keulen W, Schuurman R, Bijen M, de Graaf L, van Wijk A, Back N, Kline MW, Boucher CA, Nijhuis M.

J Infect Dis. 2002 Apr 15;185(8):1070-6. Epub 2002 Apr 1.

PMID:
11930317
45.

Pharmacokinetics and pharmacodynamics of saquinavir in pediatric patients with human immunodeficiency virus infection.

Grub S, Delora P, Lüdin E, Duff F, Fletcher CV, Brundage RC, Kline MW, Calles NR, Schwarzwald H, Jorga K.

Clin Pharmacol Ther. 2002 Mar;71(3):122-30. Review.

PMID:
11907486
46.

Combination therapy with saquinavir soft gelatin capsules in children with human immunodeficiency virus infection.

Kline MW, Brundage RC, Fletcher CV, Schwarzwald H, Calles NR, Buss NE, Snell P, DeLora P, Eason M, Jorga K, Craig C, Duff F.

Pediatr Infect Dis J. 2001 Jul;20(7):666-71.

PMID:
11465838
47.

Cancun conference report: Romanian pediatric AIDS initiative.

Kline MW.

J Int Assoc Physicians AIDS Care. 1999 Feb;5(2):17-20.

PMID:
11366253
48.

The Romanian pediatric AIDS initiative.

Kline MW.

J Int Assoc Physicians AIDS Care. 1998 Mar;4(3):37-9.

PMID:
11365178
49.
50.

Pilot study of hydroxyurea in human immunodeficiency virus-infected children receiving didanosine and/or stavudine.

Kline MW, Calles NR, Simon C, Schwarzwald H.

Pediatr Infect Dis J. 2000 Nov;19(11):1083-6.

PMID:
11099091

Supplemental Content

Loading ...
Support Center